Mode
Text Size
Log in / Sign up
N/A Completed N=76 Treatment

Effect of Music on the Sedative Use During Coronary Angioplasty

Coronary Angioplasty
Source: ClinicalTrials.gov NCT03817775 ↗
Enrolled (actual)
76
Serious AEs
0.0%
Results posted
Oct 2019
Primary outcomePrimary: Dose Use of Midazolam Medication (mg) — 3.0; 1.2 mg — p=<0.01

Summary

This is a non-blinded, non-randomized controlled pilot study with no follow-up. Patients will be recruited from the coronary angiography patient pool of the American Hospital of Paris and assigned to one of 2 groups in a non-randomized manner.

Outcome Measures

OutcomeResultp-value
PRIMARY
Dose Use of Midazolam Medication (mg)
3.0; 1.2 <0.01 sig
PRIMARY
Dose Use of Propofol Medication (mg)
12.8; 52 <0.01 sig
PRIMARY
Dose Use of Sufentanil Medication (ug)
4.9; 5.1 0.7215
SECONDARY
Pain Score
0.5; 0.7 0.5675
SECONDARY
Anxiety Score (NRS)
4.2; 2.9 <0.01 sig
SECONDARY
Satisfaction of the Patient
4.5; 4.8 —
SECONDARY
Effect on Physiological Parameters: BIS
96.9; 94.9 —
SECONDARY
Effect on Physiological Parameters: Heart Rate
71.3; 65.5 —
SECONDARY
Effect on Physiological Parameters: SpO2%
98.5; 98.9 —
SECONDARY
Effect on Physiological Parameters: Mean Arterial Blood Pressure
104.7; 104.2 —

Eligibility Criteria

Inclusion Criteria

  • Patient needs a coronary angiography
  • Patient gives verbal consent to participation in the study.

Exclusion Criteria

  • Patient aged less than 18 years at time of enrollment
  • Patient doesn't like music for cultural reason
  • Patient with serious psychiatric disorders
  • Patient with not paired deafness or paired one with devices that are incompatible with wearing a headset.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03817775). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search